Fractional Medical Leadership for biotech, medtech and specialty pharma
Gisselbaek Consulting provides senior clinical development and Medical Affairs leadership for companies approaching their next value inflection point.
I help biotech, medtech and specialty pharma companies turn scientific assets into enterprise value by defining the development path, making clinical risk visible and taking senior medical ownership of execution. Engagements can be structured as fractional CMO support, interim Medical Director capacity, defined value-inflection projects, investor due diligence support or senior review of high-stakes medical and scientific materials.
Where I create most value
- Defining clinical development strategies that are scientifically robust, operationally feasible and aligned with financing, partnering or launch objectives.
- Translating data packages into investable programmes with clear indication logic, endpoints, patient populations, comparators, timelines and risk architecture.
- Providing fractional CMO or interim Medical Director leadership when a company needs senior medical ownership before a full-time hire is justified.
- Building Medical Affairs as a lifecycle value driver through evidence generation, KOL engagement, publication planning, MSL strategy and medical-commercial governance.
- Supporting investors, boards and executive teams with independent clinical, medical and development due diligence.
Services for companies and recruitment partners
- Interim Medical Director and fractional CMO support
- Clinical development strategy consulting
- Medical Affairs consulting for pharma and biotech
- Medtech and life science advisory
- Life science investor due diligence
- Recruitment partner profile
Selected experience
- Chief Medical Officer in an orthopaedic biotech.
- Senior Medical Director, Global Clinical Development, Novo Nordisk.
- Leadership of global Phase I-IV clinical programmes.
- Medical Affairs leadership and organisation-building in international companies.
- Senior medical and scientific review in high-visibility, compliance-sensitive settings.
Recent assignment
Gisselbaek Consulting has started a new Medical Affairs consulting assignment in collaboration with Brice Group for ABACUS Medicine Pharmaceuticals, supporting senior medical strategy and hands-on execution in specialty pharma. Read the update.
Discuss your next clinical or organisational inflection point
Book an introductory call to explore how Gisselbaek Consulting can help make your programme investable, partnership-ready or launch-ready.